Upstream

Plants are an increasingly important and advantageous source of extracellular vesicles (EVs). They offer a sustainable, safe, and scalable alternative to mammalian–derived EVs. Plant-derived EVs are naturally biocompatible and exhibit low immunogenicity and toxicity, making them especially attractive for therapeutic, cosmetic, and nutraceutical applications. Unlike mammalian EVs, they carry minimal risk of transmitting human pathogens and can be produced in large quantities from easily accessible sources at relatively low cost. In addition, plant EVs are rich in bioactive lipids, proteins, and RNAs that can exert anti-inflammatory, antioxidant, and regenerative effects, and they demonstrate remarkable stability under harsh physiological conditions, including the gastrointestinal environment. Their ability to be engineered or loaded with therapeutic cargos further expands their potential as novel, eco-friendly platforms for drug delivery, diagnostics, and functional foods.

Considering these advantages that make plants prominent players in the field of EVs, we are offering our services to help researchers utilize their merits in various fields of application. In this regard, our workflows are applicable both to raw materials from plants (i.e. roots, leaves, fruits), or their extracts.